Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Deffered Revenue: 2016-2024

Historic Non-Current Deffered Revenue for Rockwell Medical (RMTI) over the last 9 years, with Dec 2024 value amounting to $429,000.

  • Rockwell Medical's Non-Current Deffered Revenue fell 9.68% to $429,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $429,000, marking a year-over-year decrease of 9.68%. This contributed to the annual value of $429,000 for FY2024, which is 9.68% down from last year.
  • According to the latest figures from FY2024, Rockwell Medical's Non-Current Deffered Revenue is $429,000, which was down 9.68% from $475,000 recorded in FY2023.
  • Rockwell Medical's 5-year Non-Current Deffered Revenue high stood at $8.0 million for FY2020, and its period low was $429,000 during FY2024.
  • For the 3-year period, Rockwell Medical's Non-Current Deffered Revenue averaged around $1.2 million, with its median value being $475,000 (2023).
  • Data for Rockwell Medical's Non-Current Deffered Revenue shows a maximum YoY tumbled of 81.73% (in 2023) over the last 5 years.
  • Rockwell Medical's Non-Current Deffered Revenue (Yearly) stood at $8.0 million in 2020, then dropped by 25.32% to $6.0 million in 2021, then plummeted by 56.57% to $2.6 million in 2022, then tumbled by 81.73% to $475,000 in 2023, then dropped by 9.68% to $429,000 in 2024.